Author:
Adih William K.,Selik Richard M.,Hall H. Irene,Babu Aruna Surendera,Song Ruiguang
Abstract
Background:
Published death rates for persons with HIV have not distinguished deaths due to HIV from deaths due to other causes. Cause-specific death rates would allow better assessment of care needs.
Methods:
Using data reported to the US national HIV surveillance system, we examined a) associations between selected decedent characteristics and causes of death during 2007-2011, b) trends in rates of death due to underlying causes among persons with AIDS during 1990-2011, and among all persons with diagnosed HIV infection (with or without AIDS) during 2000-2011.
Results:
During 2007-2011, non-HIV-attributable causes of death with the highest rates per 1,000 person-years were heart disease (2.0), non-AIDS cancers other than lung cancer (1.4), and accidents (0.8). During 1990-2011, among persons with AIDS, the annual rate of death due to HIV-attributable causes decreased by 89% (from 122.0 to 13.2), and the rate due to non-HIV-attributable-causes decreased by 57% (from 20.0 to 8.6), while the percentage of deaths caused by non-HIV-attributable causes increased from 11% to 43%. During 2000-2011, among persons with HIV infection, the rate of death due to HIV-attributable causes decreased by 69% (from 26.4 to 8.3), and the rate due to non-HIV-attributable causes decreased by 28% (from 10.5 to 7.6), while the percentage of deaths caused by non-HIV-attributable causes increased from 25% to 48%.
Conclusion:
Among HIV-infected persons, as rates of death due to HIV-attributable causes decreased, rates due to non-HIV-attributable causes also decreased, but the percentages of deaths due to non-HIV-attributable causes, such as heart disease and non-AIDS cancers increased.
Publisher
Bentham Science Publishers Ltd.
Subject
Virology,Infectious Diseases,Public Health, Environmental and Occupational Health
Reference37 articles.
1. The Antiretroviral Therapy Collaboration.
Causes of Death in HIV-infected patients treated with ART, 1996-2006: Collaborative Analysis of 13 Cohort Studies.
Clin Infect Dis
2010;
50
(10)
: 1387-96.
2. Centers for Disease Control and Prevention (CDC).
Revised surveillance case definition for HIV infection-United States, 2014.
MMWR Recomm Rep
2014;
63
(RR-03)
: 1-10.
Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm?s_cid=rr6303a1_w
3. Adih WK, Selik RM, Hu X.
Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1996-2006.
J Int Assoc Physicians AIDS Care (Chic)
2011;
10
(1)
: 5-11.
4. Detels R, Tarwater P, Phair JP, Margolick J, Riddler SA, Muñoz A.
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.
AIDS
2001;
15
(3)
: 347-55.
5. Detels R, Muñoz A, McFarlane G, et al.
Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration.
JAMA
1998;
280
(17)
: 1497-503.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献